147 related articles for article (PubMed ID: 38695944)
21. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
22. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
[TBL] [Abstract][Full Text] [Related]
23. [HRCT features differentiate synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases].
Zhou LN; Wu N; Zhao SJ; Yang L; Wang YL; Wang RB; Yang SX
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):449-455. PubMed ID: 32575939
[No Abstract] [Full Text] [Related]
24. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
Cai Y; Chen T; Zhang S; Tan M; Wang J
J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
[TBL] [Abstract][Full Text] [Related]
25. Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non-small Cell Lung Cancer Presenting as GGO-Predominant Nodule of 3 cm or Less.
Moon Y; Lee KY; Moon SW; Park JK
World J Surg; 2017 Feb; 41(2):472-479. PubMed ID: 27718002
[TBL] [Abstract][Full Text] [Related]
26. Surgical outcomes of one-stage resection for synchronous multiple primary lung adenocarcinomas with no less than three lesions.
Qu R; Tu D; Ping W; Cai Y; Zhang N; Fu X
J Cardiothorac Surg; 2021 Sep; 16(1):265. PubMed ID: 34544453
[TBL] [Abstract][Full Text] [Related]
27. Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma.
Bai J; Fu F; Sun W; Deng C; Ma Z; Wang S; Deng L; Zhang Y; Chen H
J Thorac Dis; 2023 Apr; 15(4):1559-1571. PubMed ID: 37197537
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
30. Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.
Qu R; Ye F; Hu S; Wang B; Qin S; Xiong J; Fu X; Li L; Cai Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3775-3788. PubMed ID: 35986758
[TBL] [Abstract][Full Text] [Related]
31. Comparisons of clinical outcomes in patients with and without a preoperative tissue diagnosis in the persistent malignant-looking, ground-glass-opacity nodules.
Choi SH; Chae EJ; Shin SY; Kim EY; Kim JE; Lee HJ; Oh SY; Lee SM
Medicine (Baltimore); 2016 Aug; 95(34):e4359. PubMed ID: 27559945
[TBL] [Abstract][Full Text] [Related]
32. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
Matsuguma H; Nakahara R; Anraku M; Kondo T; Tsuura Y; Kamiyama Y; Mori K; Yokoi K
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1102-6. PubMed ID: 15145016
[TBL] [Abstract][Full Text] [Related]
33. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma.
Bai J; Deng C; Fu F; Li D; Ma Z; Ma X; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1383-1389. PubMed ID: 35445333
[TBL] [Abstract][Full Text] [Related]
35. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
[TBL] [Abstract][Full Text] [Related]
36. Partly solid pulmonary nodules: waiting for change or surgery outright?
Seok Y; Cho S; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):556-60. PubMed ID: 24981106
[TBL] [Abstract][Full Text] [Related]
37. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
[TBL] [Abstract][Full Text] [Related]
38. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications.
Park JH; Lee KS; Kim JH; Shim YM; Kim J; Choi YS; Yi CA
Korean J Radiol; 2009; 10(1):12-20. PubMed ID: 19182498
[TBL] [Abstract][Full Text] [Related]
39. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
Zhang Y; Fu F; Chen H
Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
[TBL] [Abstract][Full Text] [Related]
40. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
